Literature DB >> 26400141

Creative, person-centered and narrative psychopharmacotherapy or how to prevent and overcome treatment resistance in psychiatry.

Miro Jakovljevic1.   

Abstract

Despite of the huge progress in clinical psychopharmacology and recent introduction of many new mental health medicines, a significant proportion of psychiatric patients do not respond satisfactory to pharmacological treatment. Such patients are commonly labeled "treatment resistant" although there is no full agreement about definition of the term. The precise prevalence of treatment resistance is hard to determine due to the lack of consensus regarding the term definition and too many cases of pseudo-resistance. Resistant and refractory mental disorders have significant economic, social, physical, and psychological consequences. The suffering and disability associated with chronic, unremitting mental disorders is profound. Changing treatment philosophy may be a critical step towards overcoming what some view as "therapeutic stagnation in psychiatry" and providing better treatment effectiveness and efficiency for patients benefit. A "paradigm shift" is needed from the mechanistic, formistic and reducionistic way of thinking of technical and impersonal psychopharmacology to contextual and systemic thinking with new treatment holodigm individualizing and personalizing psychopharmacotherapy in a more creative manner. Treatment resistance as a construct should be reconsidered as well as "monotherapy before polytherapy" treatment strategy. The best treatments are those that utilize and integrate multiple therapeutic modalities. The concept of creative, person-centered narrative psychopharmacotherapy gives a hope for increasing treatment effectiveness and efficiency in psychiatry.

Entities:  

Mesh:

Year:  2015        PMID: 26400141

Source DB:  PubMed          Journal:  Psychiatr Danub        ISSN: 0353-5053            Impact factor:   1.063


  2 in total

1.  What is treatment resistance in psychiatry? A "difficult to treat" concept.

Authors:  Koen Demyttenaere
Journal:  World Psychiatry       Date:  2019-10       Impact factor: 49.548

2.  Characteristics of patients expressing an interest in ketamine treatment: results of an online survey.

Authors:  Jolien K E Veraart; Sanne Y Smith-Apeldoorn; Hayley Trueman; Marrit K de Boer; Robert A Schoevers; Rupert McShane
Journal:  BJPsych Open       Date:  2018-09-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.